À louer
À vendre

Langue et région
Devise

E-mail*

Veuillez saisir une adresse e-mail valide.

Pour envoyer ce bien à plusieurs personnes, insérez un point-virgule entre l’adresse e-mail de chaque destinataire.

Message

909 caractères restants

Hum, une erreur s’est produite lors de l’envoi de votre message. Veuillez réessayer.

Votre e-mail a été envoyé.

Centre Pointe - Buildings A, B & C/D 1865-1895 W 2100 S Local d'activités 21 384 m² 100 % Loué À vendre Salt Lake City, UT 84119

.mosaic-column{display:inline-block!important;height:100%!important;width:auto!important}.mosaic-tile i{display:none!important}.mosaic-tile img{height:100%!important;width:auto!important}

Certaines informations ont été traduites automatiquement.

Informations principales sur l'investissement

Stable Cash Flow with Sticky Tenancy
Differentiated Office/R&D Asset with Exceptional Accessibility

Opportunity to Acquire Below Replacement Cost

Résumé analytique

Cushman & Wakefield, as exclusive advisor, is pleased to present the opportunity to acquire Centre Pointe Business Park ("Centre Pointe" or the “Property”), a three-building Class A flex, advanced manufacturing, and laboratory campus located in Salt Lake City, Utah. Comprising 230,180 square feet across Buildings A, B, and C/D, the Property is approximately 50% office space, with the remaining 50% comprising research and development, laboratory, and warehouse space. This balanced mix provides the flexibility to accommodate a diverse range of advanced users.
Centre Pointe recently became fully leased, providing new ownership with stable in-place income and built-in contractual lease escalations. The tenant roster includes a diverse mix of local and multinational companies operating across electronics, biopharmaceuticals, artificial intelligence, advanced materials, and immunotherapy.
Centre Pointe is well-positioned to serve the Salt Lake Valley’s growing base of advanced manufacturing, life science, and technology users. Its combination of modern, highly functional improvements, diversified tenancy, attractive in-place cash flow, and direct access to State Route 201, I-15, I-215, and I-80 creates a compelling opportunity to acquire a differentiated flex and laboratory asset within one of the region’s most connected employment corridors.

Teaser

Informations sur l’immeuble

Type de vente	Investissement	Surface utile brute	21 384 m²
Type de bien	Local d'activités	Nb d’étages	2
Sous-type de bien	Recherche et développement Industriel/logis., distribution Industriel/logis., manufacture	Année de construction/rénovation	2007/2022
Classe d’immeuble	A	Zone de développement économique [USA]	Oui Les autorités nationales désignent une partie des secteurs de recensement éligibles comme des zones de développement économique [USA]. Certains investissements dans les zones de développement économique [USA] peuvent bénéficier d’un traitement fiscal préférentiel.
Surface du lot	5,05 ha
Zonage	M-1 - Light Manufacturing

Type de vente	Investissement
Type de bien	Local d'activités
Sous-type de bien	Recherche et développement Industriel/logis., distribution Industriel/logis., manufacture
Classe d’immeuble	A
Surface du lot	5,05 ha
Surface utile brute	21 384 m²
Nb d’étages	2
Année de construction/rénovation	2007/2022
Zone de développement économique [USA]	Oui Les autorités nationales désignent une partie des secteurs de recensement éligibles comme des zones de développement économique [USA]. Certains investissements dans les zones de développement économique [USA] peuvent bénéficier d’un traitement fiscal préférentiel.
Zonage	M-1 - Light Manufacturing

Services professionnels, scientifiques et techniques
-
$9.99
Lorem Ipsum
Jan 0000

Echelon Biosciences, Inc. is a biotechnology and life sciences company focused on the development and supply of specialized research reagents, assays, and services related to lipid biology and cell signaling. Founded in 1997 as Echelon Research Laboratories by two University of Utah professors, the company was established to advance the science of lipid signaling and enable new diagnostic and therapeutic approaches for complex diseases. Echelon’s offerings include synthetic lipids, peptides, biochemical reagents, antibodies, bioassays, and lipid nanoparticle (LNP) formulation services used in academic, pharmaceutical, and biotechnology research. The company operates primarily from Salt Lake City, where it supports research, manufacturing, quality control, and administrative functions. Echelon has developed a strong reputation as a supplier of ionizable and specialty lipids used in drug delivery systems, including those relevant to mRNA-based therapeutics. In August 2024, Echelon Biosciences was acquired by Vion Biosciences and now operates as a subsidiary, continuing to serve its existing customer base while expanding its capabilities within a broader biopharmaceutical platform.

Occupant	Secteur d’activité	m² Occupés	Loyer/m²	Type de bail		Fin du bail
	Services professionnels, scientifiques et techniques	-	$9.99	Lorem Ipsum		Jan 0000